Eslizen 600mg Tablet contains Eslicarbazepine acetate, an anticonvulsant medication primarily indicated for the treatment of partial-onset seizures in adults and children over 6 years of age. Eslicarbazepine acts by stabilizing hyperexcited neuronal membranes, inhibiting repetitive neuronal firing, and reducing the propagation of seizure activity through selective blockade of voltage-gated sodium channels. This mechanism helps to restore the balance between excitatory and inhibitory neurotransmission in the central nervous system. Eslizen is typically administered orally once daily, with dosage adjustments based on clinical response and tolerability. It is important to initiate therapy at a low dose and titrate gradually to minimize adverse effects. Common side effects may include dizziness, somnolence, headache, nausea, and fatigue, which are generally mild to moderate in severity. Patients should be monitored for signs of hypersensitivity reactions, hyponatremia, and potential interactions with other antiepileptic drugs or medications metabolized by the liver. Eslizen should be used cautiously in individuals with hepatic or renal impairment. Regular follow-up and therapeutic drug monitoring are recommended to optimize efficacy and safety. This medication should be prescribed and used under the supervision of a qualified healthcare professional.